Dnome

D NOME is a pioneering company in the field of molecular diagnostics, specializing in the manufacturing and provision of indigenous diagnostic reagents. These reagents are based on proprietary, cutting-edge technologies that make genomics applications both affordable and scalable. The company was founded by two scientists with a vision to bridge the gap between academic research and industry applications. D NOME primarily serves diagnostic centers and hospitals that utilize RT PCR and genome sequencing technologies. The company's business model revolves around the development and sale of these innovative reagents, which are designed to solve operational challenges in the diagnostics sector. Revenue is generated through direct sales of these products, as well as through collaborations and product demos.

Keywords: molecular diagnostics, diagnostic reagents, genomics, RT PCR, genome sequencing, proprietary technology, affordable diagnostics, scalable solutions, healthcare innovation, operational efficiency.